• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Ceramide Scores Predict Cardiovascular Risk in the Community.神经酰胺评分预测社区人群心血管风险。
Arterioscler Thromb Vasc Biol. 2021 Apr;41(4):1558-1569. doi: 10.1161/ATVBAHA.120.315530. Epub 2021 Feb 18.
2
Plasma Ceramides.血浆神经酰胺。
Arterioscler Thromb Vasc Biol. 2018 Aug;38(8):1933-1939. doi: 10.1161/ATVBAHA.118.311199.
3
Circulating TNFSF14 (Tumor Necrosis Factor Superfamily 14) Predicts Clinical Outcome in Patients With Stable Coronary Artery Disease.循环 TNFSF14（肿瘤坏死因子超家族 14）可预测稳定性冠心病患者的临床预后。
Arterioscler Thromb Vasc Biol. 2019 Jun;39(6):1240-1252. doi: 10.1161/ATVBAHA.118.312166.
4
Astronaut Cardiovascular Health and Risk Modification (Astro-CHARM) Coronary Calcium Atherosclerotic Cardiovascular Disease Risk Calculator.宇航员心血管健康和风险修正（Astro-CHARM）冠状动脉钙动脉粥样硬化性心血管疾病风险计算器。
Circulation. 2018 Oct 23;138(17):1819-1827. doi: 10.1161/CIRCULATIONAHA.118.033505.
5
B-type natriuretic peptide trumps other prognostic markers in patients assessed for coronary disease.B 型利钠肽优于其他预后标志物，可用于评估冠心病患者。
BMC Med. 2019 Apr 3;17(1):72. doi: 10.1186/s12916-019-1306-9.
6
Galectin-3 predicts long-term cardiovascular death in high-risk patients with coronary artery disease.半乳糖凝集素-3可预测高危冠心病患者的长期心血管死亡。
Arterioscler Thromb Vasc Biol. 2015 Mar;35(3):725-32. doi: 10.1161/ATVBAHA.114.304964. Epub 2015 Jan 22.
7
Circulating FABP4 is a prognostic biomarker in patients with acute coronary syndrome but not in asymptomatic individuals.循环 FABP4 是急性冠脉综合征患者的预后生物标志物，但不是无症状个体的预后生物标志物。
Arterioscler Thromb Vasc Biol. 2015 Aug;35(8):1872-9. doi: 10.1161/ATVBAHA.115.305365. Epub 2015 Jun 11.
8
Development and validation of a ceramide- and phospholipid-based cardiovascular risk estimation score for coronary artery disease patients.基于神经酰胺和磷脂的冠心病心血管风险评估评分的开发和验证。
Eur Heart J. 2020 Jan 14;41(3):371-380. doi: 10.1093/eurheartj/ehz387.
9
Plasma C20-Sphingolipids predict cardiovascular events independently from conventional cardiovascular risk factors in patients undergoing coronary angiography.在接受冠状动脉造影的患者中，血浆C20-鞘脂独立于传统心血管危险因素预测心血管事件。
Atherosclerosis. 2015 May;240(1):216-21. doi: 10.1016/j.atherosclerosis.2015.03.011. Epub 2015 Mar 14.
10
Association of Plasma Ceramides With Myocardial Perfusion in Patients With Coronary Artery Disease Undergoing Stress Myocardial Perfusion Scintigraphy.血浆神经酰胺与冠状动脉疾病患者应激心肌灌注显像心肌灌注的相关性。
Arterioscler Thromb Vasc Biol. 2018 Dec;38(12):2854-2861. doi: 10.1161/ATVBAHA.118.311927.

引用本文的文献

1
Novel cardiac biomarkers and multiple-marker approach in the early detection, prognosis, and risk stratification of cardiac diseases.新型心脏生物标志物及多标志物方法在心脏病早期检测、预后评估及风险分层中的应用
World J Cardiol. 2025 Jul 26;17(7):106561. doi: 10.4330/wjc.v17.i7.106561.
2
Ceramides in cardiovascular disease: emerging role as independent risk predictors and novel therapeutic targets.心血管疾病中的神经酰胺：作为独立风险预测因子和新型治疗靶点的新作用。
Cardiovasc Res. 2025 Aug 14;121(9):1345-1358. doi: 10.1093/cvr/cvaf093.
3
Glucosylated cholesterol accumulates in atherosclerotic lesions and impacts macrophage immune response.糖基化胆固醇在动脉粥样硬化病变中蓄积，并影响巨噬细胞免疫反应。
J Lipid Res. 2025 Jun;66(6):100825. doi: 10.1016/j.jlr.2025.100825. Epub 2025 May 15.
4
The role of sphingolipids in heart failure.鞘脂类在心力衰竭中的作用。
Eur Heart J Open. 2025 May 2;5(3):oeaf035. doi: 10.1093/ehjopen/oeaf035. eCollection 2025 May.
5
Serum and plasma sphingolipids as biomarkers of chemotherapy-induced cardiotoxicity in female patients with breast cancer.血清和血浆鞘脂作为乳腺癌女性患者化疗引起的心脏毒性的生物标志物。
J Lipid Res. 2025 May;66(5):100798. doi: 10.1016/j.jlr.2025.100798. Epub 2025 Apr 5.
6
Ceramide in Coronary Artery Disease: Troublesome or Helpful Future Tools in the Assessment of Risk Prediction and Therapy Effectiveness?冠状动脉疾病中的神经酰胺：评估风险预测和治疗效果时麻烦还是有用的未来工具？
Metabolites. 2025 Mar 1;15(3):168. doi: 10.3390/metabo15030168.
7
Plasma lipidomic alterations during pathogenic SIV infection with and without antiretroviral therapy.致病性猴免疫缺陷病毒感染期间，接受和未接受抗逆转录病毒治疗时的血浆脂质组学改变。
Front Immunol. 2025 Mar 10;16:1475160. doi: 10.3389/fimmu.2025.1475160. eCollection 2025.
8
A Mendelian randomization study on associations between plasma lipidome, circulating inflammatory proteins, and erectile dysfunction.一项关于血浆脂质组、循环炎症蛋白与勃起功能障碍之间关联的孟德尔随机化研究。
Transl Androl Urol. 2024 Dec 31;13(12):2724-2734. doi: 10.21037/tau-24-378. Epub 2024 Dec 28.
9
Air pollution and coronary atherosclerosis.空气污染与冠状动脉粥样硬化。
Future Cardiol. 2025 Jan;21(1):53-66. doi: 10.1080/14796678.2025.2451545. Epub 2025 Jan 9.
10
Ceramide-based risk score CERT-1 improves risk prediction for overall mortality and adverse cardiovascular outcomes in patients with and without cardiovascular disease: A prospective cohort study.基于神经酰胺的风险评分CERT-1改善了有或无心血管疾病患者的全因死亡率和不良心血管结局的风险预测：一项前瞻性队列研究。
Diabetes Obes Metab. 2025 Mar;27(3):1488-1497. doi: 10.1111/dom.16156. Epub 2024 Dec 26.

本文引用的文献

1
Ceramides improve atherosclerotic cardiovascular disease risk assessment beyond standard risk factors.神经酰胺除了改善标准风险因素外，还能改善动脉粥样硬化性心血管疾病的风险评估。
Clin Chim Acta. 2020 Dec;511:138-142. doi: 10.1016/j.cca.2020.10.005. Epub 2020 Oct 12.
2
The Accuracy of Cardiovascular Pooled Cohort Risk Estimates in U.S. Older Adults.美国老年人心血管合并队列风险评估的准确性
J Gen Intern Med. 2020 Jun;35(6):1701-1708. doi: 10.1007/s11606-019-05361-4. Epub 2019 Oct 30.
3
Development and validation of a ceramide- and phospholipid-based cardiovascular risk estimation score for coronary artery disease patients.基于神经酰胺和磷脂的冠心病心血管风险评估评分的开发和验证。
Eur Heart J. 2020 Jan 14;41(3):371-380. doi: 10.1093/eurheartj/ehz387.
4
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.2019 ACC/AHA 心血管疾病一级预防指南：执行摘要：美国心脏病学会/美国心脏协会临床实践指南工作组的报告。
J Am Coll Cardiol. 2019 Sep 10;74(10):1376-1414. doi: 10.1016/j.jacc.2019.03.009. Epub 2019 Mar 17.
5
2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.2018 年美国心脏病学会/美国心脏协会/美国心血管血管造影和介入学会/美国预防、物理治疗和康复医师学会/美国糖尿病协会/美国老年学会/美国药学会/美国医师协会/美国生理学会/北美介入放射学会/美国国家脂质协会/美国临床内分泌医师协会胆固醇管理指南：美国心脏病学会/美国心脏协会临床实践指南工作组的报告。
Circulation. 2019 Jun 18;139(25):e1082-e1143. doi: 10.1161/CIR.0000000000000625. Epub 2018 Nov 10.
6
Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017: a systematic analysis for the Global Burden of Disease Study 2017.全球、区域和国家按年龄、性别和死因分类的死亡率，195 个国家和地区，1980-2017 年：2017 年全球疾病负担研究的系统分析。
Lancet. 2018 Nov 10;392(10159):1736-1788. doi: 10.1016/S0140-6736(18)32203-7. Epub 2018 Nov 8.
7
Ceramides as Novel Disease Biomarkers.神经酰胺作为新型疾病生物标志物。
Trends Mol Med. 2019 Jan;25(1):20-32. doi: 10.1016/j.molmed.2018.10.009. Epub 2018 Nov 23.
8
Plasma Ceramides.血浆神经酰胺。
Arterioscler Thromb Vasc Biol. 2018 Aug;38(8):1933-1939. doi: 10.1161/ATVBAHA.118.311199.
9
Ceramide Remodeling and Risk of Cardiovascular Events and Mortality.神经酰胺重塑与心血管事件和死亡风险。
J Am Heart Assoc. 2018 May 3;7(10):e007931. doi: 10.1161/JAHA.117.007931.
10
Coronary Artery Calcium Scoring: Is It Time for a Change in Methodology?冠状动脉钙评分：是否需要改变方法？
JACC Cardiovasc Imaging. 2017 Aug;10(8):923-937. doi: 10.1016/j.jcmg.2017.05.007.

神经酰胺评分预测社区人群心血管风险。

Ceramide Scores Predict Cardiovascular Risk in the Community.

机构信息

Department of Laboratory Medicine and Pathology (V.C.V., J.W.M., L.J.D., A.S.J.), Mayo Clinic College of Medicine, Rochester, MN.

Department of Cardiovascular Diseases (V.C.V., J.R.M.J., R.R.R., F.L.-J., A.S.J.), Mayo Clinic College of Medicine, Rochester, MN.

出版信息

Arterioscler Thromb Vasc Biol. 2021 Apr;41(4):1558-1569. doi: 10.1161/ATVBAHA.120.315530. Epub 2021 Feb 18.

DOI:10.1161/ATVBAHA.120.315530
PMID:33596665
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8939859/
Abstract

[Figure: see text].

摘要

[图：见正文]。